Author:
Ismailova S. B.,Prokopenko S. V.,Pokhabov D. V.,Mosaleva E. I.,Alekseenko P. V.,Zhumzhanov I. M.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. T. Pringsheim, N. Jette, A. Frolkis, and T. D. Steeves, “The prevalence of Parkinson’s disease: a systematic review and meta-analysis,” Mov. Disord., 29, 1583–1590 (2014), https://doi.org/10.1002/mds.25244.
2. A. B. Singleton, M. J. Farrer, and V. Bonifati, “The genetics of Parkinson’s disease: progress and therapeutic implications,” Mov. Disord., 28, 14–23 (2013), https://doi.org/10.1007/978-3-319-17223-1_2.
3. O. S. Levin and L. V. Dokadina, “Epidemiology of parkinsonism and Parkinson’s disease,” Nevrol. Zh., 10, No. 5, 41–49 (2005), https://www.elibrary.ru/ip_restricted.asp?rpage=https%3A%2F%2Fwww%2Eelibrary%2Eru%2Fitem%2Easp%3Fid%3D9136241.
4. B. Pascual-Sedano, J. Kulisevsky, M. Barbanoj, et al., “Levodopa and executive performance in Parkinson’s disease: A randomized study,” J. Int. Neuropsychol. Sol., 14, No. 5, 832–841 (2008), https://doi.org/10.1017/S1355617708081010.
5. K. W. Lange, T. W. Robbins, C. D. Marsden, et al., “L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction,” Psychopharmacology, 107, 394–404 (1992), https://doi.org/10.1007/bf02245167.